Quantamental Technologies LLC Hutchmed (China) LTD Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$17.17 - $25.95 $10,731 - $16,218	-625 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$17.84 - $22.69 $38,480 - $48,942	-2,157 Reduced 77.53%	625 $11,000
Q2 2019 Aug 12, 2019	BUY	$22.0 - $31.78 $52,558 - $75,922	2,389 Added 607.89%	2,782 $61,000
Q1 2019 Apr 29, 2019	SELL	$21.27 - $30.58 $36,286 - $52,169	-1,706 Reduced 81.28%	393 $12,000
Q4 2018 Jan 28, 2019	BUY	$23.09 - $37.69 $48,465 - $79,111	2,099 New	2,099 $48,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.5B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.